During hospitalization, the NMS symptoms were first subsided, CPK and lactate dehydrogenase (LDH) levels decreased (Figure 1), the symptoms of catatonic symptoms were subsided, then psychotic symptoms appeared and delirium symptoms became gradually noticeable. This evidence concerns the gene PIK3C2A and neuroleptic malignant syndrome.